$3.7 billion (2011 revenue)
10,400+ Employees
1,500+ Scientists
160+ Countries
50,000+ Products
4,000+ Patents
600,000+ Citations
Corporate Brochure
We are a global life sciences company
We believe in the power of science and appreciate its rigorous discipline. That’s what drives our passion for innovation, leading to transformative offerings that support endeavors throughout the world.
Our extensive range of products and services, from instruments to everyday lab essentials, ensures quality and performance for every lab, every application. Customers in more than 160 countries count on us in their quest to improve life in meaningful ways.
- Research Sciences
- Cell Biology
- Genetic Analysis
- Molecular Biology
- Applied Sciences
- Agriculture Biology
- Animal Health
- Bioproduction
- Food Safety
- Human Identification
- Synthetic Biology
- Medical Sciences
- Genomic Medicine
- Molecular Diagnostics
- Regenerative Medicine
- Transplant Diagnostics

Learn more about Life Technologies as an investment opportunity by accessing corporate governance information, news releases, presentations and events, SEC filings, and financial documents.
Learn More >

Our employees are inspired by knowing their efforts are helping to improve the world of science and medicine. The Careers section allows candidates to explore exciting career opportunities at Life Technologies and details our global events.
Learn More >

Stay connected to the latest news generated from Life Technologies and coverage from the global media. The Corporate Communications department is also available to assist reporters with their inquiries.
Learn More >
Global Citizenship
As a global citizen, we are constantly searching for new ways to transform how we use energy and natural resources. Since 2008, we reduced our:
Learn More >
The Ion Proton Sequencer was honored with the prestigious international Red Dot award for design - 2012
Safe Harbor Statement:
Certain statements contained in this site are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and Life Technologies intends that such forward-looking statements be subject to the safe harbor created thereby. Such forward-looking statements include, but are not limited to, statements related to financial projections, including revenue and non-GAAP earnings per share;
momentum in 2012 and beyond; plans to sustain and expand organic growth and increase operating margins; success in acquired businesses, including cost controls; development and increased flow of new products; leveraging technology and personnel; advanced opportunities and efficiencies; opportunities for growth; expectations of prospective new standards, new delivery platforms, and new selling specialization and effectiveness; and Life Technologies' plans, objectives, expectations and strategy for its business. Such forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from future results express or implied by such forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.